1 |
Gurbuz C, Canat L, Atis G, Guner B, Caskurlu T. The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk. Kaohsiung Journal of Medical Sciences. 2012;28:649-653. https://doi.org/10.1016/j.kjms.2012.02.003
DOI
|
2 |
Morgentaler A, Rhoden EL. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less. Urology. 2006. 68(6):1263-1267. https://doi.org/10.1016/j.urology.2006.08.1058
DOI
|
3 |
Koo JM, Shim BS. Significance of serum testosterone for prostate-specific antigen (PSA) elevation and prediction of prostate cancer in patients with PSA above 10 ng/ml. Korean Journal of Urology. 2010;51:831-835. https://doi.org/10.4111/kju.2010.51.12.831
DOI
|
4 |
Zhang J, Ma M, Nan X. Sheng B. Obesity inversly correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China. Brazillian Journal of Medical and Biological Research. 2016;49(8):e5272. https://doi.org/10.1590/1414-431X20165272
DOI
|
5 |
Khera M, Crawford D, Morales A, Salonia A, Morgentaler A. A new era of testosterone and prostate cancer: from physiology to clinical implication. European Urology. 2014;65(1):115-123. https://doi.org/10.1016/j.eururo.2013.08.015
DOI
|
6 |
Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A. et al. High-grade prostate cancer is associated with low serum testosterone levels. Prostate. 2001;47:52-58. https://doi.org/10.1002/pros.1046
DOI
|
7 |
Boyle P, Koechlin A, Bota M, d'Onofrio A, Zaridze DG, Perrin P, et al. Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis. BJU International. 2016;118:731-741. https://doi.org/10.1111/bju.13417
DOI
|
8 |
Walsh TJ, Shores MM, Krakauer CA, Forsberg CW, Fox AE, Moore KP, et al. Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels. Plos One 2018;13(6):e0199194. https://doi.org/10.1371/journal.pone.0199194
DOI
|
9 |
Morote J, Ramirez C, Gomez E, Planas J, Raventos CX, de Torres IM, et al. The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness. BJU International. 2009;104:486-9. https://doi.org/10.1111/j.1464-410X.2009.08378.x
DOI
|
10 |
Albisinni S, De Nunzio C, Tubaro A, Barry WT, Banez LL, Freedland SJ. Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy. Urology. 2012;80(1):162-167. https://doi.org/10.1016/j.urology.2012.01.068
DOI
|
11 |
Rastrelli G, Corona G, Vignozzi L, Maseroli E, Silveril A, Monami M et al. Serum PSA as a predictor of testosterone deficiency. Journal of Sex Medicine. 2013;10:2518-2528. https://doi.org/10.1111/jsm.12266
DOI
|
12 |
McLaren D, Siemens DR, Izard J, Black A, Morales A. Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome. BJU International. 2008;102(9):1142-1146. https://doi.org/10.1111/j.1464-410X.2008.07811.x.
DOI
|
13 |
Albuquerque GAML, Guglielmetti GB, Barbosa JABA, Pontes Jr. J, Fazoli AJC, Cordeiro MD et al. Low serum testosterone is a predictor of high-grade disease in patient with prostate cancer. Revista da Associacao Medica Brasileira. 2017;63(8):704-710. https://doi.org/10.1590/1706-9282.63.08.704
DOI
|
14 |
Arunprasad K, Chandramohan. Association between low serum testosterone and prostate cancer behaviour. International Journal of Contemporary Medical Research. 2018;5(8):H1-H4. https://doi.org/10.21276/ijcmr.2018.5.8.3
|
15 |
Favilla V, Cimino S, Castelli T, Madonia M, Barbagallo I. Morgia G. Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia. BJU International. 2010;106:1700-1703. https://doi.org/10.1111/j.1464-410X.2010.09459.x
DOI
|
16 |
Haider A, Zitzmann M, Doros G, Isbam H, Hammerer P, Yassin A. Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median follow up of 3 registries. Journal of Urology. 2016;193(1):80-86. https://doi.org/10.1016/j.juro.2014.06.071
DOI
|
17 |
Armola RR, Bourgault AM, Halm MA, Board RM, Bucher L, Harrington L et al. Upgrading the American Association of Critical-Care Nurses' evidence-leveling hierarchy. American Journal of Critical Care. 2009;18(5):405-409. https://doi.org/10.4037/ajcc2009170
DOI
|
18 |
Cooper CS, MacIndoe JH, Perry PJ, Yates WR, Williams RD, The effect of exogenous testosterone on total and free prostate specific antigen levels in healthy young men. Journal of Urology. 1996;156:438-441. https://doi.org/10.1097/00005392-199608000-00028
DOI
|
19 |
Gerstenbluth RE, Maniam PN, Corty EW, Seftel AD. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement. Journal of Andrology. 2002;23(6):922-926. https://doi.org/10.1002/j.1939-4640.2002.tb02351.x
|
20 |
Whittemore R, Knafl K. The integrative review: updated methodology. Journal of Advanced Nursing. 2005;52(5):546-553. https://doi.org/10.1111/j.1365-2648.2005.03621.x
DOI
|
21 |
Mermall H, Sothern RB, Kanabrocki EL, Quadri SF, Bremner FW, Nemchausky BA, et al. Temporal (circadian) and functional relationship between prostate-specific antigen and testosterone in healthy men. Urology. 1995;46(1):45-53. https://doi.org/10.1016/S0090-4295(99)80157-5
DOI
|
22 |
Mifsud A, Choon AT, Fang D, Yong EL. Proste-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men. Molecular Human Reproduction. 2001;7(11):1007-1013. https://doi.org/10.1093/molehr/7.11.1007
DOI
|
23 |
Sofikerim M, Oruc O, Eskicorapci S, Guliyev F, Ozen H. Correlation of serum androgen and pituitary hormone levels with serum PSA less than 2.5ng/ml. The Scientific World Journal. 2007;7:1128-1133. https://doi.org/10.1100/tsw.2007.177
DOI
|
24 |
Mustafa M, Celik M, Horsanali O, Horuz R, Kucukcan A. Relationship between serum PSA and testosterone levels in two different geographic regions of Turkey. Turkish Journal of Urology. 2011; 37: 9-13. https://doi.org/10.5152/tud.2011.002
DOI
|
25 |
Elzanaty S, Rezanezhad B, Dohle G. Association between serum testosterone and PSA levels in middle-aged healthy men from the general population. Current Urology. 2016;10:40-44. https://doi.org/10.1159/000447149
DOI
|
26 |
Mustafa M, Horuz R, Celik M, Kucukcan A. Is there an association between serum prostate-specific antigen values and serum testosterone levels in healthy men? Korean Journal of Urology. 2014;55:465-468. https://doi.org/10.4111/kju.2014.55.7.465
DOI
|
27 |
Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, et al. Circulating total testosterone and PSA concentrations in a nationally representive sample of men without a diagnosis of prostatic cancer. Prostate. 2015;75(11):1167-1176. https://doi.org/10.1002/pros.22998
DOI
|
28 |
Mustafa M, Nurigorgel S, Horsanali O, Abu Khadija HA, Marashde OM. PSA and testosterone serum levels in the Middle east: Is there a difference? Journal of Urology and Research. 2015;2(2):1028-1031.
|
29 |
Shin YS, You JH, Cha JS, Park JK. The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men. Aging Male. 2016;19(4):209-214. https://doi.org/10.1080/13685538.2016.1229764
DOI
|
30 |
Shukla A, Sharda B, Sharma S, Bhardwaj S, Kailash U, Kalani R, et al.. Association between serum testosterone and serum PSA among men with and without partial androgen deficiency. Indian Journal of Clinical Biochemistry. 2020;35(1):127-131. https://doi.org/10.1007/s12291-018-0785-3
DOI
|
31 |
Morgentaler A. Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. European Urology. 2009;55(2):310-321. https://doi.org/10.1016/j.eururo.2008.09.024
DOI
|
32 |
Partin AW, Catalona WJ, Southwick PC, Subong EN, Gasior GH, Chan DW. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology. 1996;48:55-61. https://doi.org/10.1016/s0090-4295(96)00611-5
DOI
|
33 |
Plymate SR, Tenover JS, Bremner WJ. Circadian variation in testosterone, sex hormone -binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young men and elderly men. Journal of Andrology. 1989;10(5):366-371. https://doi.org/10.1002/j.1939-4640.1989.tb00120.x
DOI
|
34 |
Shea JL, Wong PY, Chen Y. Free testosterone: clinical utility and important analytical aspects of measurement. Advances in Clinical Chemistry. 2014;63:59-84. https://doi.org/10.1016/b978-0-12-800094-6.00002-9
DOI
|
35 |
Choi YD, Kang DR, Nam CM, Kim YS, Cho SY, Kim SJ, et al. Age-specific prostate-specific antigen reference ranges in Korean men. Urology. 2007;70(6):1113-1116. https://doi.org/10.1016/j.urology.2007.07.063
DOI
|
36 |
Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. Journal of Urology. 1994;151(6):1571-1574. https://doi.org/10.1016/s0022-5347(17)35304-1
DOI
|
37 |
Kilic S, Yalcinkaya S, Guntekin E, Kukul E, Deger N, Sevuk M. Determination of the site of metabolism of total, free, and complexed prostate-specific antigen. Urology. 1998;52(3):470-473. https://doi.org/10.1016/s0090-4295(98)00208-8
DOI
|
38 |
Vicentini FC, Botelho LA, Hisano M, Ebaid GX, Lucon M, Lucon AM, et al. Are total prostate-specific antigen serum levels in cirrhotic men different from those in normal men? Urology. 2009;73(5):1032-1035. https://doi.org/10.1016/j.urology.2009.01.015
DOI
|
39 |
Wichendu PN, Odum EP, Amdi C, Aleme BM. Endogenous testosterone to prostate-specific antigen relationship in men without prostatic disease: a 10-year retrospective study. International Surgery Journal. 2018;5(4):1186-1191. https://doi.org/10.18203/2349-2902.isj20181099
DOI
|
40 |
National Cancer Information Center. Annual report on the prevalences of cancer [Internet]. Goyang: National Cancer Center; 2020 [cited 2020 Feb 22]. Available from https://www.cancer.go.kr/lay1/S1T639C641/contents.do
|
41 |
Akdogan M, Hassoun BS, Guraker A, El-Sahwi K, Jazzar A. Wright H. et al. Prostate-specific antigen levels among cirrhotic patients. International Journal of Biological Markers. 2002;17:161-164. https://doi.org/10.1177/172460080201700303
DOI
|